CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.47 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2014-11-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2014-09-30 was -$1.90M, a 34093.56% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2014-06-30 was $418.54K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2014-03-31 was $11.46K, a 74.34% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2013-09-30 was $5.59K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2014-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.48M derived: sum of 2 quarters · filed 2014-11-14 | -$1.47M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $418.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $430.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $11.46K 10-Q · filed 2014-05-15 | ||
| 2013-09-30 | $5.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$687.51K derived: sum of 2 quarters · filed 2014-11-14 | -$642.85K 10-Q · filed 2014-11-14 |
| 2013-06-30 | -$693.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$648.44K 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $44.66K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |